Array BioPharma’s ARRY-797 Meets Primary Endpoint in Clinical Proof of Concept Trial in Osteoarthritis Patients Whose Pain is Poorly Controlled by NSAIDs Array BioPharma (NASDAQ: ARRY) today announced ...

Singapore’s Sun Cable is eyeing up what would be the world’s biggest solar project by some distance. Australia’s Northern Territory government is on board with the plans and an environmental approval ...

Array BioPharma Inc.'s p38-alpha kinase inhibitor, ARRY-797, hit its primary endpoint of reducing pain more than placebo in a Phase II proof-of-concept trial in 157 patients with knee pain due to ...